Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26942239 | 0.90 | RYR2 (0.63) | RYR2KCNH2 | |
| SCHEMBL26344324 | 0.87 | RYR2 (0.58) | RYR2KCNH2 | |
| SCHEMBL6867303 | 0.87 | RYR2 (0.72) | RYR2KCNH2 | |
| SCHEMBL6866744 | 0.85 | RYR2 (0.54) | RYR2 | |
| SCHEMBL6866991 | 0.84 | RYR2 (1.00) | RYR2KCNH2 | |
| SCHEMBL24460327 | 0.82 | RYR2 (0.65) | RYR2KCNH2 | |
| SCHEMBL29563318 | 0.82 | RYR2 (0.65) | RYR2KCNH2 | |
| SCHEMBL6867081 | 0.82 | RYR2 (0.75) | RYR2KCNH2 | |
| SCHEMBL26344276 | 0.81 | RYR2 (0.53) | RYR2 | |
| Hydrochloric Acid SCHEMBL29563284 | 0.81 | RYR2 (0.64) | RYR2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399324-A1 | AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS | RYCARMA THERAPEUTICS, INC. | 2023-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399324-A1 | AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS | RYR2, RYR1, ATP2A1 | RYR2 1/4885KCNH2 605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.